公司资料
SpringWorks Therapeutics 股价、新闻与催化剂
- 股票代码:
- SWTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SWTX.
公司概览
业务概览
SpringWorks Therapeutics is a rare-disease and oncology biotech focused on targeted treatments for genetically defined conditions. Its story blends commercial execution with a highly focused pipeline.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, SpringWorks sits in specialty biopharma.
商业模式特征
The company combines product revenue with pipeline development, so investors watch launch progress, label expansion, and regulatory milestones.
生物医药行业定位
SpringWorks is a focused specialty-biotech name whose stock can move sharply on data and commercial milestones.
未来催化剂
- SpringWorks's catalysts are nirogacestat in desmoid tumors and mirdametinib in NF1-PN, both of which can move the stock if commercial and late-stage execution stay clean. The company is still building its rare-disease franchise.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。